Ubs Group Ag Abbott Laboratories Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Abbott Laboratories stock. As of the latest transaction made, Ubs Group Ag holds 525,657 shares of ABT stock, worth $53.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

525,657

Previous 7,211,523 92.71%

Holding current value

$53.7 Million

Previous $794 Million 92.47%

% of portfolio

0.02%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $69.7 Million - $77 Million	636,207 Added 8.82%	7,847,730 $892 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $2.12 Million - $2.6 Million	-23,531 Reduced 0.33%	7,211,523 $794 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $3.86 Million - $4.64 Million	40,440 Added 0.56%	7,235,054 $701 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $6.07 Million - $6.77 Million	-60,265 Reduced 0.83%	7,194,614 $784 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $34.6 Million - $40.8 Million	357,665 Added 5.19%	7,254,879 $735 Million

Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $96.7 Million - $113 Million	1,017,028 Added 17.3%	6,897,214 $757 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $24.6 Million - $28.5 Million	-254,710 Reduced 4.15%	5,880,186 $569 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $23.5 Million - $28.4 Million	-230,325 Reduced 3.62%	6,134,896 $667 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $46.9 Million - $57.2 Million	411,693 Added 6.92%	6,365,221 $753 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $15.2 Million - $18.6 Million	131,340 Added 2.26%	5,953,528 $838 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $17.3 Million - $19.2 Million	148,519 Added 2.62%	5,822,188 $688 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $44 Million - $51.8 Million	-416,134 Reduced 6.83%	5,673,669 $658 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $130 Million - $154 Million	1,198,955 Added 24.51%	6,089,803 $730 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $46.3 Million - $50.5 Million	441,403 Added 9.92%	4,890,848 $536 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $5.01 Million - $6.09 Million	-54,694 Reduced 1.21%	4,449,445 $484 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $14.3 Million - $18.2 Million	186,183 Added 4.31%	4,504,139 $412 Million
Q1 2020 May 01, 2020	SELL	$62.82 - $91.86 $43.9 Million - $64.2 Million	-698,986 Reduced 13.93%	4,317,956 $341 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $64.7 Million - $72 Million	824,041 Added 19.65%	5,016,942 $436 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $7.9 Million - $8.56 Million	-96,507 Reduced 2.25%	4,192,901 $351 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $7.7 Million - $8.98 Million	105,688 Added 2.53%	4,289,408 $361 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $19.5 Million - $23.6 Million	295,105 Added 7.59%	4,183,720 $334 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $16 Million - $18.2 Million	-244,486 Reduced 5.92%	3,888,615 $281 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.6 Million - $1.94 Million	26,388 Added 0.64%	4,133,101 $303 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $18.2 Million - $20.1 Million	-316,798 Reduced 7.16%	4,106,713 $250 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $24.2 Million - $27.3 Million	-429,651 Reduced 8.85%	4,423,511 $265 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $36.3 Million - $38.8 Million	675,831 Added 16.18%	4,853,162 $277 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $7.77 Million - $8.67 Million	-161,686 Reduced 3.73%	4,177,331 $223 Million
Q2 2017 Aug 14, 2017	BUY	N/A	137,396 Added 3.27%	4,339,017 $211 Million
Q1 2017 Nov 14, 2017	BUY	N/A	4,201,621	4,201,621 $187 Million

Others Institutions Holding ABT

# of Institutions

3,124

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account